Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma-Reference-Cited by-同舟云学术

Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma

Published:2021-03 Issue:3 Volume:14 Page:101010
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Watanabe Takafumi^ORCID,Nanamiya Hideaki,Kojima Manabu,Nomura Shinji,Furukawa Shigenori,Soeda Shu,Tanaka Daisuke,Isogai Takao^ORCID,Imai Jun-ichi,Watanabe Shinya,Fujimori Keiya

Funder

Fukushima Prefecture

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

2. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis;Sohaib;Clin. Radiol.,2007

3. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium;Pecorelli;Int. J. Gynaecol. Obstet.,2009

4. Current status of molecular biomarkers in endometrial cancer;Werner;Curr. Oncol. Rep.,2014

5. The cancer genome;Stratton;Nature,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis in endometrial cancer: clinical and biological significance;Siberian journal of oncology;2024-09-10

2. Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. The Downregulation of MMP23B Facilitates the Suppression of Vitality and Induction of Apoptosis in Endometrial Cancer Cells;Reproductive Sciences;2024-05-23

4. Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146;Journal for ImmunoTherapy of Cancer;2024-01

5. The role and participation of immune cells in the endometrial tumor microenvironment;Pharmacology & Therapeutics;2023-11